Literature DB >> 35796849

Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study.

Duy L Nguyen1, Nghia A Nguyen1,2, Toan D Pham1, Minh H N Nguyen1, Lan N Vuong3,4.   

Abstract

PURPOSE: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte developmental competence and can enhance embryo quality. There is currently no follow-up data on babies born from CAPA-IVM. This study investigated developmental outcomes in children born after CAPA-IVM versus natural conception.
METHODS: This prospective cohort study was conducted at a fertility clinic in Vietnam in August/September 2019. Children born after CAPA-IVM were propensity score-matched with those born after natural conception. All parents were asked to complete the Developmental Red Flags and Ages & Stages Third Edition (ASQ-3) questionnaires.
RESULTS: A total of 46 parents (23 in each group) of 55 babies (31 CAPA-IVM and 24 natural conception) were included in the study. Baseline characteristics, including mother's age and body mass index, gestational age at delivery, and birth weight, were comparable. The mean age of children at the end of follow-up was 15 months. The overall proportion of children with any abnormal ASQ-3 score was 6.5% in the CAPA-IVM group and 20.8% in the natural conception group (p = 0.24). The proportion of children with a developmental red flag did not differ significantly between the CAPA-IVM and natural conception groups (9.7% vs. 4.2%; p = 0.80).
CONCLUSIONS: The use of CAPA-IVM did not have any significant impact on childhood physical and mental development compared with children born as a result of natural conception.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ASQ-3; Capacitation; Childhood development; In vitro fertilization; In vitro maturation; Red Flag sign

Mesh:

Year:  2022        PMID: 35796849      PMCID: PMC9428089          DOI: 10.1007/s10815-022-02559-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  25 in total

1.  In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.

Authors:  Mausumi Das; Weon-Young Son; William Buckett; Togas Tulandi; Hananel Holzer
Journal:  Reprod Biomed Online       Date:  2014-08-12       Impact factor: 3.828

2.  Prospective evaluation of the Ages and Stages Questionnaire 3rd Edition in very-low-birthweight infants.

Authors:  Pratibha K Agarwal; Luming Shi; Lourdes M Daniel; Phey Hong Yang; Poh Choo Khoo; Bin Huey Quek; Qishi Zheng; Victor S Rajadurai
Journal:  Dev Med Child Neurol       Date:  2016-11-24       Impact factor: 5.449

3.  Developmental Milestones.

Authors:  Rebecca J Scharf; Graham J Scharf; Annemarie Stroustrup
Journal:  Pediatr Rev       Date:  2016-01

4.  DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients.

Authors:  M D Saenz-de-Juano; E Ivanova; S Romero; F Lolicato; F Sánchez; H Van Ranst; F Krueger; A Segonds-Pichon; M De Vos; S Andrews; J Smitz; G Kelsey; E Anckaert
Journal:  Hum Reprod       Date:  2019-09-29       Impact factor: 6.918

5.  An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.

Authors:  F Sánchez; F Lolicato; S Romero; M De Vos; H Van Ranst; G Verheyen; E Anckaert; J E J Smitz
Journal:  Hum Reprod       Date:  2017-10-01       Impact factor: 6.918

6.  Growth and development of children conceived by in-vitro maturation of human oocytes.

Authors:  Mu Shu-Chi; Hwang Jiann-Loung; Lin Yu-Hung; Sung Tseng-Chen; Lin Ming-I; Yeh Tsu-Fuh
Journal:  Early Hum Dev       Date:  2006-05-11       Impact factor: 2.079

Review 7.  In vitro maturation: Clinical applications.

Authors:  Kyung Sil Lim; Soo Jin Chae; Chang Woo Choo; Yeon Hee Ku; Hye Jun Lee; Chang Young Hur; Jin Ho Lim; Won Don Lee
Journal:  Clin Exp Reprod Med       Date:  2013-12-31

8.  ASQ3 and/or the Bayley-III to support clinicians' decision making.

Authors:  Robin Mackin; Nadya Ben Fadel; Jana Feberova; Louise Murray; Asha Nair; Sally Kuehn; Nick Barrowman; Thierry Daboval
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 9.  The Place of In Vitro Maturation in PCO/PCOS.

Authors:  Shital Julania; Melanie L Walls; Roger Hart
Journal:  Int J Endocrinol       Date:  2018-07-31       Impact factor: 3.257

Review 10.  IVM results are comparable and may have advantages over standard IVF.

Authors:  A Ellenbogen; T Shavit; E Shalom-Paz
Journal:  Facts Views Vis Obgyn       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.